Clinical Research Directory
Browse clinical research sites, groups, and studies.
BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY
Sponsor: Parc de Salut Mar
Summary
Endocrine therapy is the mainstay of adjuvant therapy in premenopausal women with hormone receptive-positive (HR+) breast cancer as it has been demonstrated that it reduces long-term recurrences and increases survivial. However, this therapy, which suppresses estrogen production and estrogen-induced effects, is associated with the development of joint pain which can significantly reduce quality of life and lead to treatment discontinuation. The main question the study aims o answer is: Can balneotherapy (BT) alleviate muscle-skeletal pain (primary objective) derived from endocrine therapy and improve quality of life (secondary objective) in young women with HR+ breast cancer?
Official title: EFFECTS OF BALNEOTHERAPY IN BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY
Key Details
Gender
FEMALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
96
Start Date
2025-02-10
Completion Date
2027-05-31
Last Updated
2025-02-03
Healthy Volunteers
No
Interventions
Balneotherapy
The intervention consists in 3 weekly sessions of balneotherapy during 4 weeks.
Locations (1)
Parc de Recerca Biomèdica de Barcelona
Barcelona, Spain